Is there Co-infection of Influenza and Covid-19 in Jos, North Central Nigeria?

Nathan Yakubu Shehu, Mark Ojogba Okolo, Emmanuel Ameh Ameh, Daniel Geofrey Thankgod, Oluwatoyin Ruth Morenikeji, Ferdinand Ibu Ogbaji, Dung Davou Pam, Filibus Danjuma Dami, Pam Dachung Luka
{"title":"Is there Co-infection of Influenza and Covid-19 in Jos, North Central Nigeria?","authors":"Nathan Yakubu Shehu, Mark Ojogba Okolo, Emmanuel Ameh Ameh, Daniel Geofrey Thankgod, Oluwatoyin Ruth Morenikeji, Ferdinand Ibu Ogbaji, Dung Davou Pam, Filibus Danjuma Dami, Pam Dachung Luka","doi":"10.71480/nmj.v66i1.342","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Influenza virus and severe acute respiratory syndrome virus-2 (SARS CoV-2) are known to cause respiratory disease in humans that may be fatal. They have caused epidemics and constitute significant public health challenges because of their ability to spread and cause severe disease. Co-infection with both viruses has been shown to increase the odds of fatality among affected patients. Our study aimed to investigate co-infection with influenza among patients with coronavirus disease-2019 (COVID-19) in Jos, Plateau State.</p><p><strong>Methodology: </strong>We carried out a cross-sectional study using stored nasopharyngeal and oropharyngeal samples of patients diagnosed with COVID-19 using GeneXpert. The samples were collected at our institution and stored at -80 °C. The samples were analysed for influenza co-infection using real-time reverse transcriptase polymerase chain reaction.</p><p><strong>Results: </strong>Two-hundred-and-forty-one (241) stored samples of patients diagnosed with COVID-19 were analysed. None of the samples tested positive for the influenza virus.</p><p><strong>Conclusion: </strong>We found no case of influenza and SARS-CoV-2 co-infection among the patients studied. This suggests that the prevalence of influenza virus infection may be low in our setting and partly explains the relatively benign outcome of SARS-CoV-2 infections in our region.</p>","PeriodicalId":94346,"journal":{"name":"Nigerian medical journal : journal of the Nigeria Medical Association","volume":"66 1","pages":"357-363"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12038622/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nigerian medical journal : journal of the Nigeria Medical Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.71480/nmj.v66i1.342","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Influenza virus and severe acute respiratory syndrome virus-2 (SARS CoV-2) are known to cause respiratory disease in humans that may be fatal. They have caused epidemics and constitute significant public health challenges because of their ability to spread and cause severe disease. Co-infection with both viruses has been shown to increase the odds of fatality among affected patients. Our study aimed to investigate co-infection with influenza among patients with coronavirus disease-2019 (COVID-19) in Jos, Plateau State.

Methodology: We carried out a cross-sectional study using stored nasopharyngeal and oropharyngeal samples of patients diagnosed with COVID-19 using GeneXpert. The samples were collected at our institution and stored at -80 °C. The samples were analysed for influenza co-infection using real-time reverse transcriptase polymerase chain reaction.

Results: Two-hundred-and-forty-one (241) stored samples of patients diagnosed with COVID-19 were analysed. None of the samples tested positive for the influenza virus.

Conclusion: We found no case of influenza and SARS-CoV-2 co-infection among the patients studied. This suggests that the prevalence of influenza virus infection may be low in our setting and partly explains the relatively benign outcome of SARS-CoV-2 infections in our region.

尼日利亚中北部乔斯是否存在流感和Covid-19合并感染?
背景:已知流感病毒和严重急性呼吸综合征病毒-2 (SARS CoV-2)可引起人类呼吸道疾病,可能是致命的。由于它们能够传播和引起严重疾病,它们已造成流行病,并构成重大的公共卫生挑战。两种病毒的合并感染已被证明会增加受感染患者的死亡率。本研究旨在调查高原州乔斯市冠状病毒病-2019 (COVID-19)患者的合并流感感染情况。方法:我们对使用GeneXpert诊断为COVID-19的患者储存的鼻咽和口咽样本进行了横断面研究。样品收集于本机构,保存于-80°C。使用实时逆转录酶聚合酶链反应对样本进行流感合并感染分析。结果:共分析了241份COVID-19患者存储样本。所有样本的流感病毒检测结果均未呈阳性。结论:本研究未发现流感和SARS-CoV-2合并感染病例。这表明流感病毒感染的流行率在我们的环境中可能很低,并在一定程度上解释了我们地区SARS-CoV-2感染的相对良性结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信